Oncology Certified Nurse (OCN) Nursing Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the Oncology Certified Nurse Exam with our detailed QandA format. Gain confidence with flashcards and multiple-choice questions, complete with hints and explanations to understand concepts deeply. Excel in your OCN certification journey!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which chemotherapy drug is known for its effectiveness in treating malignant melanoma?

Cisplatin
Dacarbazine
Paclitaxel
Vincristine

The correct answer is: Dacarbazine

Dacarbazine is recognized as an effective chemotherapy drug for treating malignant melanoma due to its mechanism of action and specific application in this type of cancer. It is an alkylating agent that works by interfering with the DNA of cancer cells, ultimately leading to apoptosis or cell death. Historically, dacarbazine has been one of the first-line treatment options for patients with metastatic melanoma, particularly before the advent of newer immunotherapies and targeted therapies. In the context of malignancy, particularly melanoma, the use of dacarbazine is supported by clinical evidence demonstrating its efficacy in improving outcomes for patients with this aggressive form of skin cancer. Additionally, it is often used in combination with other agents to enhance therapeutic outcomes, although the treatment landscape has evolved with the introduction of newer options like immune checkpoint inhibitors and targeted therapies. Understanding the specific role of dacarbazine helps oncology nurses appreciate how treatment protocols can differ based on the type and stage of cancer, ultimately guiding effective patient care.